In severe bilateral cases of anophthalmia and microphthalmia, a genetic cause has been identified in approximately 80% of cases, with de novo heterozygous loss-of-function point mutations in SOX2 being the most common, accounting for 10–20% of cases [2, 16]. The gene discussed is SOX2; the disease is Anophthalmia.